COVID-19 and MSC Clinical Trials

COVID-19 and MSC Clinical Trials

The immunomodulatory properties of hu-MSCs may prove valuable in the treatment of severe COVID-19 cases Mesenchymal stem cells (aka MSCs) aren’t new. Scientists first discovered and isolated MSCs 30 years ago more, and since then more than 5,000 articles focused on...
A 40-Year Pandemic With Little Attention

A 40-Year Pandemic With Little Attention

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease in human history, with probable ties to countless deaths through the ages.  Although NAFLD has always existed, it wasn’t clinically characterized until the 1980s.  In the almost 40 years of...